Company / Current Assets
Supernus Pharmaceuticals, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$644.2M
FY2025
5-year range
$493.1M / $734.2M
FY2021-FY2025
Trend
-6.1%
vs FY2024
Sector context
#93 of 213
Health Care
What the data says
At $644M, Supernus Pharmaceuticals, Inc.'s current assets ranks #93 of 213 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $151M in FY2016 to $734M in FY2022.
Based on SEC 10-K filings.
$644M in FY2025 with a 5-year CAGR of +0.4%.
Improved from $493M to $644M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -4.3%
- 5-Year CAGR
- +0.4%
- 10-Year CAGR
- -
Sector benchmark
#93 of 213 in Health CareTop 44% of 213This company $644.2M Sector average $2.5B
▼
-74.5% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.4%, indicating consistent growth.
- In FY2025, current assets decreased 6.1% year-over-year.
- Ranks #93 out of 213 companies in the Health Care sector.
- Peak current assets was recorded in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $644.2M | -6.1% |
| FY2024 | $686.1M | +39.1% |
| FY2023 | $493.1M | -32.8% |
| FY2022 | $734.2M | +22.0% |
| FY2021 | $601.6M | -4.6% |
| FY2020 | $630.4M | +33.4% |
| FY2019 | $472.6M | -4.2% |
| FY2018 | $493.5M | +116.0% |
| FY2017 | $228.5M | +50.9% |
| FY2016 | $151.4M | +42.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026